COO coopercos.com: Likuiditas cepet

The Cooper Companies (COO) dominates the women's health and optics niche, benefiting from high demand for daily disposable lenses and a stable cash flow. An analysis of quick liquidity helps assess the business's solvency, where the 0.70 mark reflects the latest data. Success is driven by R&D investments and a team of scientists, while stability is guaranteed by the balance between the ophthalmology and surgical divisions.

This metric measures the ability of The Cooper Companies (COO) to instantaneously settle short-term debts using cash and accounts receivable, completely ignoring inventory. By analyzing the acid-test ratio, an investor assesses the issuer's real solvency without accounting for illiquid assets. The stability of this metric confirms the financial resilience of The Cooper Companies (COO). The non-cyclical demand for ophthalmology products guarantees a constant cash inflow, minimizing the risk of cash flow gaps.